PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA
P. Davey, N. Rajan, Y. Kanivets, H. Barraclough, M. Orlando, A.J. Brnabic, B. HanVolume:
14
Year:
2011
Language:
english
DOI:
10.1016/j.jval.2011.02.894
File:
PDF, 57 KB
english, 2011